5 unknown. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Unknown 5 |
Follow Menopause: new trials by email Literature Review of Menopause trials Research Report on Menopause
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| the Effects of Different Therapy Regimens on Menopausal Sleep Disorders Tibolone, Xiangshao granules, Tibolone plus Xiangshao granules - Menopause, Sleep Disorder | Phase 4 | Unknown | Peking Union Medical College Hospital | 180 | 2023-12-30 | 2024-01-02 |
| A New Hormone Replacement Paradigm: Physiologic Restoration Study Compounded topical estradiol and compounded topical progesterone in a carrier cream - Menopause, Perimenopausal Disorder | Phase 4 | Unknown | Women's Hormone Network | 100 | 2020-06-01 | 2020-04-01 |
| Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life Estradiol, Placebo - Menopause, Atherosclerosis | Phase 4 | Unknown | Hanna Savolainen-Peltonen | 150 | 2020-02-19 | 2021-02-15 |
| Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women Vaginal progesterone 8% - Menopause, Sexual Desire Disorder | Phase 4 | Unknown | Bezmialem Vakif University | 30 | 2016-07-01 | 2017-10-20 |
| Kronos Early Estrogen Prevention Study (KEEPS) Conjugated equine estrogens 0.45 mg/day, Transdermal estradiol, 50 mcg/day, Micronized progesterone, 200 mg/day x 12 d/month - Menopause, Arteriosclerosis | Phase 4 | Unknown | Kronos Longevity Research Institute | 728 | 2005-09-01 | 2009-09-14 |
Arteriosclerosis (1) · Atherosclerosis (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Sexual Dysfunctions, Psychological (1) · Sleep Wake Disorders (1)
Arterial Occlusive Diseases (2) · Mental Disorders (2) · Vascular Diseases (2) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Heart Diseases (1) · Myocardial Ischemia (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Estradiol (2) · 2-chloroethyl ethyl sulfide (1) · Estrogens, Conjugated (USP) (1) · Progesterone (1) · Transdermal Patch (1) · tibolone (1)
Bezmialem Vakif University (1) · Hanna Savolainen-Peltonen (1) · Kronos Longevity Research Institute (1) · Peking Union Medical College Hospital (1) · Women's Hormone Network (1)
Finland (1) · Turkey (Türkiye) (1) · United States (1)
Dennis M Black, PhD (1) · Frederick Naftolin, MD, PhD (1) · Howard Hodis, MD (1) · Julie Taguchi, MD (1) · Matthew Budoff, MD (1) · Michael Mendelsohn, MD (1) · Rong Chen, Professor (1) · S Mitchell Harman, MD, PhD (1) · Sanjay Asthana, MD (1) · Serdar G Aydin, M.D (1) · Tomi Mikkola, MD, PhD (1)
PMID 19657788, PMID 19996872, PMID 22209479, PMID 22587616, PMID 23312232, PMID 23322818, PMID 23670850, PMID 23874743, PMID 25069991, PMID 26035291, PMID 27393520, PMID 28364870, PMID 28846767, PMID 31078511, PMID 31652073, PMID 32015261, PMID 32520900, PMID 36395695, PMID 39729067, PMID 41618732